CDMO - Avid Bioservices, Inc.
Earnings Results

Avid Bioservices, Inc. ( $CDMO )

Recent earnings result

  1. Avid Bioservices EPS beats by $0.04, beats on revenue

Events & Presentations

Avid Bioservices, Inc CDMO CEO Nick Green on Q1 2021 Results

Supporting docs

  1. Listen to webcast

Top Stories (CDMO)

Events & Annual meetings

Title Date Webcast
Avid Bioservices, Inc CDMO CEO Nick Green on Q1 2021 Results 9/2/2020 webcast
Outsourced Pharma Oct 16, 2019
Biotech Week Boston Sep 9 - Sep 12, 2019
First Quarter Year 2020 Financial Results Conference Call Sep 5, 2019   4:30 PM EDT webcast
Avid Bioservices, Inc.Shareholder Meeting Oct 9, 2019   10:15 AM PDT webcast

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and Current Good Manufacturing Practices (CGMP) commercial manufacturing services focused on biopharmaceutical products derived from mammalian cell culture for biotechnology and pharmaceutical companies.

Videos about Avid Bioservices, Inc.


The Content is made available for informational purposes only. The Content may not be complete and may be subject to change.
The Content is provided without any warranty of any kind, either express or implied.
We have collected the events here to help investors easily find the informations they need.
These are manually collected by our researchers directly from Official IR pages and not third party sources.

Recent results

Books we are reading